Breakfast and Industry Symposium 

Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture
Presented by Afshin Gangi, MD, PhD

HCC Tumor Board (200 Level Education)
Moderated by Sarah White, MD, MS, FSIR, and Beau Toskich, MD

• Laura Crocetti, MD, PhD, EBIR
• Jin Woo Choi, MD, PhD
• Pretesh R. Patel, MD
• Riad Salem, MD, MBA
• Alessandro Vitale, MD

Critical Studies (200 Level Education)
Moderated by Edward Kim, MD, FSIR, Terence P. Gade, MD, PhD, and Philippe L. Pereira, MD

• RETNET: Driving a Study to Completion and Implications, Michael C. Soulen, MD, FSIR, FCIRSE
• ACCLAIM: Where Are We? Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE
• CHOPIN: Closing Out a Study and Findings, Mark Burgmans, MD
• COVERALL: Delivering a Study with Difficult Concepts, Bruno C. Odisio, MD, PhD, FSIR
• Cryoablation in Metastatic Melanoma: Development and Findings in a Fundamental Study, Florian J. Fintelmann, MD
• ENFORCE: What to Test and How in Prostate Cancer, Jurgen Futterer, MD, PhD
• Emerald Pipeline: 1/3/Y90, Joseph Erinjeri, MD, PhD

GU Session (200 Level Education)
Moderated by Vijay Ramalingam, MD, FSIR, and David Woodrum, MD, PhD

• Prostate Cancer: Treatment Decision Making, Timothy D. McClure, MD
• Anatomic Considerations in Focal Treatment, Guilherme Mariotti, MD, MSc, PhD, MBA
• Focal Treatment in Prostate: The Best Way to Do It, David Woodrum, MD, PhD
• Renal Cancer Ablation: What is the Current Place of Ablation and Have We Agreed a Standardized Procedure? Thomas D. Atwell, MD
• Roundtable Discussion: Challenging Cases, Alex King, MBBS, FRCR, and Vijay Ramalingam, MD, FSIR

y90 Dosimetry & Hands-on Workshop

• Introductory Lectures, Irene Bargellini, MD
• y90 Dosimetry Made Easy: What IRs Need to Know, Marnix Lam, MD, PhD
• y90 Dosimetry: Current Guidelines in Primary Liver Lesions, Nora Elizabeth Tabori, MD
• y90 Dosimetry: Current Guidelines in Liver Metastases, Ammar Sarwar, MD FSIR
• The Importance of Spheres' Concentration and Distribution: Tyler Sandow, MD
• Case 1: Radiation Segmentectomy, Siddharth A. Padia, MD
• Case 2: Radiation Lobectomy, Zachary Berman, MD
• Case 3: Multifocal Liver Mets, Roberto Iezzi, MD, FCIRSE

Exhibit Hall Networking

Discovery Theater

• Publishing in Interventional Oncology 
  Moderated by Michael C. Soulen, MD, FSIR, FCIRSE and Riad Salem, MD, MBA 

  • Publishing in the IO Space: The View from CVIR Oncology, Thomas Helmberger, MD 

  • Publishing in the IO Space: How Should SIO Proceed?, Daniel Sze, MD, PhD 

  • Discussion 

• Industry Product Theatre

Grants Session (300 Level Education)
Moderated by Terence P. Gade, MD, PhD, Julius Chapiro, MD, PhD, and Christopher D. Malone, MD

• Welcome and SIO Grant Program Introduction, Terence P. Gade, MD, PhD
• Understanding the Influence of Hepatocellular Carcinoma Tumor Immune Microenvironment on Response to y-90 Radioembolization and Potential Combinations with Immune Checkpoint Inhibition, Christopher D. Malone, MD
• Spatial Proteogenomics for Prediction of Response in Combined Radioembolization and Immunotherapy of HCC, Elif Ocal, MD
• Discussion

Beyond the Liver: In collaboration with the Society for Immunotherapy of Cancer (SITC) (300 Level Education) 
Moderated by Rony Avritscher, MD, and Tulia C. Bruno, PhD

• IO's Role in the Development and Application of Antitumoral Vaccines
• Immunoscoring and TLCs as a Biomarker of Response to Local Therapy
• Biomechanical Issues in Intratumoral Interventions
• Lessons Learned from Melanoma to RCC Therapy?
• IO Approaches to Overcoming Barriers in CAR-T Cell Delivery

OMD Tumor Board [Non-Hepatic] (200 Level Education)
Moderated by Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, and David Breen, MD, FRCR

• Alda Tam, MD
• Robert Liddell, MD
• Alexandra Hotca-Cho, MD
• Dimitrios Filippiadis, MD, PhD, MSc, EBIR
• Michael Rutenberg, MD, PhD

Emerging Non-Thermal Ablation: Clinical Applications
Moderated by Paul Laeseke, MD, PhD, and Marwan Moussa, MD

• Limitations of Thermal Ablation, Erica Knavel Koepsel, MD
• IRE: Role in the Liver, Man-Deuk Kim, MD, PhD, FSIR
• Current Status, Data, and Limitations of Histotripsy, Mishal Mendiratta-Lala, MD
• Electrochemotherapy in Palliation, Frederic Deschamps, MD
• PEF in Advanced Lung Cancer: Where are We? William Moore, MD

Scientific Oral Abstracts (200 Level Education)

Locally Advanced Pancreatic Cancer: Adding the Local Approach (300 Level Education)
Presented by William Rilling, MD, FSIR, and Govindarajan Narayanan, MD

• State of the Art Optimal Chemotherapy [mFolfirinox / Gem-nabPac] and Radiotherapy Consolidation
• Understanding the Difficult TME of LAPC, Nadine Abi-Jaoudeh, MD
• IRE, Panfire-2 and Crossfire: What Have We Learned? Hester J. Scheffer, MD
• Emerging Locoregional Technologies and Energies, Martijn R. Meijerink, MD, PhD, FCIRSE
• Adjunctive Intra-arterial Approaches, Paula Novelli, MD, FSIR

Industry Product Theater

Metastatic Liver Session: mCRC and mNET (200 Level Education)
Moderated by Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE

• mNET: Current Role of y90? Ghassan El-Haddad, MD
• mNET: LDT for Grade 3 Disease, Nicholas Fidelman, MD
• Assessment of FLR Function: How? David C. Madoff, MD
• Optimal Strategies for Venous Deprivation? Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE
• In Light of COLLISION: Optimal Approach to Bilobar Disease - IR Perspective, Martijn R. Meijerink, MD, PhD, FCIRSE
• In Light of COLLISION: Optimal Approach to Bilobar Disease - Surgeons Perspective Cases, Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE
• Cases: Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE 

• Critical Role of Surgical Oncology, Matthew Goodwin, MD, PhD
• State of the Art Palliative Radiation and SBRT, Clifford G. Robinson, MD
• IR Role in the Multidisciplinary Treatment, Matthew R. Callstrom, MD, PhD
• Multidisciplinary Tumor Board, Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, and Steven Yevich, MD, MPH, with Matt Goodwin, MD, PhD, Clifford G. Robinson, MD, and Matthew R. Callstrom, MD, PhD

Saturday Soiree Social Event*

Additional registration required

Private Practice Forum: New Arenas (200 Level Education)
Moderated by Jason R. Levy, MD, FSIR, and Juan Camacho, MD

• Business Case to Clients and Strategy for Building IO in the Hospital Based Setting, Jason R. Levy, MD, FSIR
• Business Case for Building IO in an OBL Setting, Charles W. Nutting, DO, FSIR
• Thyroid Ablation for Primary Thyroid Cancer, Juan Camacho, MD
• Breast Cryoablation: Current Indications and Technical Updates and Payment Models, Kenneth Tomkovich, MD
• Roundtable Discussion

Evidence-Based Illustrative Case Review (200 Level Education)
Moderated by Nicholas Fidelman, MD

• Case 1: Lymphatics, Jinoo Kim, MD
• Case 2: Thyroid, Wei-Che Lin, MD
• Case 3: Difficult mCRC, Stephen Hunt, MTR, MD, PhD, FSIR
• Case 4: Adrenal, Shamar J. Young, MD
• Case 5: Sarcoma / Soft Tissue, Robert Luigi Cazzato, MD, PhD
• Case 6: Vascular Emergencies in IO, Charles J. Kim, MD
• Case 7: T1b RCC, AJ Gunn, MD